Steven Weber

Insider Reports History

Entity
Individual
Location
C/O Aeglea Biotherapeutics, Inc., 805 Las Cimas Parkway, Suite 100, Austin, TX
Signature
/s/ Misbah Tahir, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven Weber:

Stock Role Class Num Shares Value Price $ Report Date Ownership
IGM Biosciences, Inc. PRINCIPAL ACCOUNTING OFFICER Common Stock 31.7K $237K $7.48 Dec 16, 2024 Direct
IGM Biosciences, Inc. PRINCIPAL ACCOUNTING OFFICER Stock Option (right to buy) 37.5K Mar 12, 2024 Direct
Aeglea BioTherapeutics, Inc. VP, Controller&Princ Acctg Off Employee Stock Option (right to buy) 30K Feb 17, 2022 Direct

Insider Reports Filed by Steven Weber

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IGMS IGM Biosciences, Inc. Dec 16, 2024 1 -$4.03K 4 Dec 18, 2024 PRINCIPAL ACCOUNTING OFFICER
IGMS IGM Biosciences, Inc. Nov 7, 2024 1 $0 4 Nov 12, 2024 PRINCIPAL ACCOUNTING OFFICER
IGMS IGM Biosciences, Inc. Sep 13, 2024 1 -$5.41K 4 Sep 17, 2024 PRINCIPAL ACCOUNTING OFFICER
IGMS IGM Biosciences, Inc. Jun 14, 2024 1 -$3.75K 4 Jun 18, 2024 PRINCIPAL ACCOUNTING OFFICER
IGMS IGM Biosciences, Inc. Mar 13, 2024 2 -$9.94K 4 Mar 15, 2024 PRINCIPAL ACCOUNTING OFFICER
IGMS IGM Biosciences, Inc. Mar 12, 2024 2 $0 4 Mar 14, 2024 PRINCIPAL ACCOUNTING OFFICER
IGMS IGM Biosciences, Inc. Apr 4, 2023 2 $0 4 Apr 6, 2023 Principal Accounting Officer
IGMS IGM Biosciences, Inc. May 25, 2022 0 $0 3 Jun 3, 2022 Principal Accounting Officer
AGLE Aeglea BioTherapeutics, Inc. Feb 17, 2022 1 $0 4 Feb 22, 2022 VP, Controller&Princ Acctg Off